Abstract:Abstract Background Thoracic aortic aneurysm and dissection (TAAD) comprises a heterogenous group of cardiovascular urgencies, which could be further categorized into syndromic and non-syndromic entities. The accurate and timely identification of culprit genetic variants is of grave importance for TAAD patients, since different genetic defects have been associated with different risks for aortic dissection, thus different thresholds for preventive aortic intervention. Purpose With the advent of next-generation sequencing (NGS) techniques, accumulating records of rare variants have been found in TAAD patients, while inadequate functional validation also makes it difficult to give proper counsel for individual TAAD patients. Therefore, it is necessary for us to start re-evaluating clinical applications of genetic screening strategies in specific patient populations. Methods From June 2016 to July 2017, genetic screening using an NGS-based panel of 18 candidate genes (FBN1, FBN2, TGFBR1, TGFBR2, TGFB2, TGFB3, SMAD3, COL1A1, COL3A1, COL5A2, COL5A1, PLOD1, ACTA2, MYH11, MYLK, PRKG1, MFAP5, and SKI) was applied in 109 adult TAAD patients from our institution. Patients with bicuspid aortic valve disease, complex congenital cardiac defect, aortic root infection, aortitis, pregnancy, and an age older than 70 years were excluded from the present study. Results Among 109 TAAD patients, 36 harboured an FBN1 variant, including 2 splicing site, 6 frame shift, 5 non-sense, and 23 mis-sense variants. The pathogenicity of mis-sense variants was further categorized into 10 disease-causing variants via database survey, 5 disease-causing variants via family survey, and 8 variants of uncertain significance (VUS). On the other hand, 25 patients harboured a non-FBN1 variant, including 3 established pathogenic variants on TGFBR1, TGFB2, and ACTA2 genes, as well as 22 VUS. Patients with an FBN1 variant displayed younger age, lower rate of hypertension, higher rate of aortic root aneurysm, and more frequent mitral valve prolapse, while an extreme male predominance (24/25) was observed in patients with a non-FBN1 variant. Conclusion In an adult Chinese TAAD cohort, disease-causing genetic variants were found in 28.4% (31/109) of patients, with FBN1 mutations still being the single leading cause of disease. The present study advocated a genetic screening strategy emphasizing the detection of FBN1 mutations in adult Chinese TAAD patients, and further studies should address the pathogenicity and clinical relevance of non-FBN1 VUS in TAAD patients.

Three Novel Mutations in FBN1 and TGFBR2 in Patients with the Syndromic Form of Thoracic Aortic Aneurysms and Dissections.

Exon 47 Skipping of Fibrillin-1 Leads Preferentially to Cardiovascular Defects in Patients with Thoracic Aortic Aneurysms and Dissections

Fibrillin-1 (FBN1) Mutations in Patients With Thoracic Aortic Aneurysms

Systemic Mutational Analysis Of The Tgfb Signalling Pathway In Thoracic Aortic Aneurysms And Dissections

Whole-Exome Sequencing Identified Genes Responsible for Thoracic Aortic Aneurysms and Dissections in Three Chinese Families

P6499Genetic Screening in 109 Adult Chinese Patients with Thoracic Aortic Aneurysm and Dissection

Novel LTBP3 Mutations Associated with Thoracic Aortic Aneurysms and Dissections.

Study on the FBN1 Gene Mutation Spectrum and Association Between Genotype and Clinical Phenotype in 300 Marfan Syndrome Patients and Their Relatives

The Research of Causative Genes and Phenotypic Features in Chinese Families with Thoracic Aortic Aneurysm and Dissec-Tion

Whole Exome Sequencing Identifies FBN1 Mutations in Two Patients with Early-Onset Type B Aortic Dissection

Molecular Characterization and Clinical Investigation of Patients with Heritable Thoracic Aortic Aneurysm and Dissection.

Two novel mutations of fibrillin-1 gene correlate with different phenotypes of Marfan syndrome in Chinese families.

A FBN1 Mutation Association with Different Phenotypes of Marfan Syndrome in a Chinese Family.

Identification of Novel Clinically Relevant Variants in 70 Southern Chinese Patients with Thoracic Aortic Aneurysm and Dissection by Next-generation Sequencing

Novel Non-Synonymous Mutation in the Transforming Growth Factor Beta Binding Protein-Like (TB) Domain of the Fibrillin-1 (FBN1) Gene in a Han Chinese Family with Marfan Syndrome (MFS).

A Novel FBN1 Heterozygous Mutation Identified in a Chinese Family with Autosomal Dominant Marfan Syndrome.

Mutations of the TGFBR2 Gene in Chinese Patients with Marfan-related Syndrome

Two de novo mutations including 1 novel mutation in FBN1 and genotype-phenotype correlation in 2 Chinese Marfan syndrome families

A Novel Mutation in Fibrillin-1 Gene Identified in a Chinese Family with Marfan Syndrome.

[Analysis of FBN1 Gene Mutations in Two Pedigrees Affected with Marfan Syndrome].

Increased Frequency of FBN1 Frameshift and Nonsense Mutations in Marfan Syndrome Patients with Aortic Dissection